Back to Portfolio
IPDx OU
MedTechImmunoprofiling diagnostics for personalized treatment decisions.
ImmunologyDiagnosticsPrecision MedicineOncology
Invested
2020
Founded
2018
Headquarters
Tallinn, Estonia
Sector
MedTech
About
IPDx developed immunoprofiling diagnostics technology that analyzed patients' immune system responses to guide personalized treatment decisions. The platform aimed to improve outcomes in oncology and infectious disease management through precision immunology.